Hormonal Contraception and Breast Cancer Risk

Research output: Contribution to journalArticle


Contemporary hormonal contraception formulations contain lower doses of estrogen, have new synthetic progestin components, and provide novel methods of delivery that have not been studied extensively in relation to breast cancer risk. Given that hormonal contraception is the leading method of birth control in the United States, it is important to reevaluate risk using current formulations. Recent studies including contemporary hormonal contraception formulations will be described.

Original languageEnglish (US)
JournalAmerican Journal of Lifestyle Medicine
Publication statusAccepted/In press - Jan 1 2018


All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Health Policy
  • Public Health, Environmental and Occupational Health

Cite this